• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • ERA-NET TRANSCAN
        • Alternative Methods to Animal Testing
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Minor Groove of DNA as Target for Drug Design

Minor Groove of DNA as Target for Drug Design

Klaus R. Liedl (ORCID: 0000-0002-0985-2299)
  • Grant DOI 10.55776/P19756
  • Funding program Principal Investigator Projects
  • Status ended
  • Start April 1, 2007
  • End March 31, 2012
  • Funding amount € 201,846

Disciplines

Chemistry (50%); Medical-Theoretical Sciences, Pharmacy (50%)

Keywords

    DNA, Drug Design, Minor Groove, Pharmacophore Modeling, Transcription Control, Virtual Screening

Abstract Final report

In the recent years minor groove binding molecules have been found to influence DNA-dependent processes giving rise to an uncommon but very promising pathway for drug design: their affinity is high enough to prevent DNA binding enzymes from interaction with the DNA. Some of the minor groove binders can even be designed to target only specific DNA sequences. Thereby they are able to influence transcription control providing the possibility to systematically regulate the synthesis of proteins which take part in the course of diseases. Unfortunately, all highly sequence selective minor groove binders have the same scaffold, which includes a number of amide bonds and therefore lacks metabolic stability. Although the basic structural pattern of known ligands is always more or less the same, many slight variations of minor groove binding polypyrroles have been synthesized and subjected to detailed investigations. Therefore there is a great amount of data available, providing a firm basis for our project. We consider pharmacophore modeling methods to be the optimal tool to merge experimental data. This will lead to a deeper understanding of sequence specific properties of DNA-binding small molecules and to models able to reproduce the phenomenon. It will be a challenging task to adapt computational methods designed to describe protein-ligand interactions to the needs of DNA-ligand complex description. The resulting models will be used within virtual screening of libraries containing purchasable substances. Isothermal titration calorimetry (ITC) will help to validate and refine the pharmacophores which in a last step will be applied to virtual combinatorial library screening. This procedure promises new findings in the area of minor groove binding ligands. Our experience in the field of nucleic acid research combined with our experience in the field of pharmacophore modeling and virtual screening qualifies us optimally for this research.

Desoxyribonucleic acid DNA passes over genetic information from one generation to the next. Information is stored as base pairs in DNA, whereas the individual readout of information (genes) is controlled by DNA-binding proteins (transcription factors). Binding of transcription factors can be influenced by small molecule minor groove binders, binding directly to the minor groove of DNA in contrast to conventional drugs targeting proteins. Hence, DNA minor groove binders provide a novel and general way to treat genetic diseases, rendering the minor grove of DNA as target for drug design. Currently available DNA minor groove binders are derived from a narrow range of chemical scaffolds. These compounds suffer from low bioavailability and are therefore usually not considered in current drug design efforts. Thus, goal of the project was to overcome these limitations and to search for novel molecules binding to the minor groove of DNA. After thorough analyses of available structural data, computational similarity searches were carried out to identify novel DNA minor groove binder candidates based on available minor groove binders and their 3D structures, when bound to DNA. This was accomplished by pharmacophore-based search as well as shape- based virtual screening and validated with sets of known minor groove binders. Pharmacophore approaches were found highly successful in reproducing sequence specificity of known binders, whereas shape-based virtual screening was identified as perfectly suitable and rapid method to retrieve candidate molecules from large virtual molecule databases. In the course of the project several novel minor groove binders were identified and verified experimentally. Binding affinity was assessed by UV spectroscopy, minor groove binding by NMR spectroscopy. Isothermal titration calorimetry experiments were carried out to record thermodynamic profiles of minor groove binding leading to novel insights into sequence-specific DNA binding. These thermodynamic contributions were investigated by molecular dynamics simulations that shed further light on the connections between sequence- dependent DNA shape and binding characteristics. Especially, minor groove solvation was identified as a crucial point in the prediction of sequence-dependent DNA binding, which is followed up by further on-going projects in the group.

Research institution(s)
  • Universität Innsbruck - 100%
International project participants
  • Gerhard Klebe, Philipps-Universität Marburg - Germany

Research Output

  • 548 Citations
  • 11 Publications
Publications
  • 2010
    Title One Concept, Three Implementations of 3D Pharmacophore-Based Virtual Screening: Distinct Coverage of Chemical Search Space
    DOI 10.1021/ci100136b
    Type Journal Article
    Author Spitzer G
    Journal Journal of Chemical Information and Modeling
    Pages 1241-1247
  • 2007
    Title DNA Minor Groove Pharmacophores Describing Sequence Specific Properties
    DOI 10.1021/ci600500v
    Type Journal Article
    Author Spitzer G
    Journal Journal of Chemical Information and Modeling
    Pages 1580-1589
  • 2009
    Title How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information
    DOI 10.1021/ci8004226
    Type Journal Article
    Author Kirchmair J
    Journal Journal of Chemical Information and Modeling
    Pages 678-692
  • 2009
    Title Hydrogen-Bonding Patterns of Minor Groove-Binder-DNA Complexes Reveal Criteria for Discovery of New Scaffolds
    DOI 10.1021/ci800455f
    Type Journal Article
    Author Spitzer G
    Journal Journal of Chemical Information and Modeling
    Pages 1063-1069
  • 2008
    Title Discovery of Novel CB2 Receptor Ligands by a Pharmacophore-Based Virtual Screening Workflow
    DOI 10.1021/jm801044g
    Type Journal Article
    Author Markt P
    Journal Journal of Medicinal Chemistry
    Pages 369-378
  • 2008
    Title Discovery of Novel PPAR Ligands by a Virtual Screening Approach Based on Pharmacophore Modeling, 3D Shape, and Electrostatic Similarity Screening
    DOI 10.1021/jm800128k
    Type Journal Article
    Author Markt P
    Journal Journal of Medicinal Chemistry
    Pages 6303-6317
  • 2008
    Title The Protein Data Bank (PDB), Its Related Services and Software Tools as Key Components for In Silico Guided Drug Discovery
    DOI 10.1021/jm8005977
    Type Journal Article
    Author Kirchmair J
    Journal Journal of Medicinal Chemistry
    Pages 7021-7040
  • 2008
    Title Discovery of Novel Cathepsin S Inhibitors by Pharmacophore-Based Virtual High-Throughput Screening
    DOI 10.1021/ci800101j
    Type Journal Article
    Author Markt P
    Journal Journal of Chemical Information and Modeling
    Pages 1693-1705
  • 2008
    Title Sequence-Specific Positions of Water Molecules at the Interface between DNA and Minor Groove Binders
    DOI 10.1002/cphc.200800647
    Type Journal Article
    Author Spitzer G
    Journal ChemPhysChem
    Pages 2766-2771
  • 2011
    Title Development of anti-viral agents using molecular modeling and virtual screening techniques.
    DOI 10.2174/187152611794407782
    Type Journal Article
    Author Kirchmair J
    Journal Infectious disorders drug targets
    Pages 64-93
  • 2011
    Title Minor Groove Binders and Drugs Targeting Proteins Cover Complementary Regions in Chemical Shape Space
    DOI 10.1021/ci200237c
    Type Journal Article
    Author Fuchs J
    Journal Journal of Chemical Information and Modeling
    Pages 2223-2232

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF